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Secondary glutamate transporters in neuronal and
glial cells in the mammalian central nervous system re-
move the excitatory neurotransmitter glutamate from
the synaptic cleft and prevent the extracellular gluta-
mate concentration to rise above neurotoxic levels. Sec-
ondary structure prediction algorithms predict 6 trans-
membrane helices in the first half of the transporters
but fail in the C-terminal half where no clear helix-loop-
helix motif is resolved in the hydropathy profile of the
primary sequences. A number of previous studies have
emphasized the importance of the C-terminal half of the
molecules for the function. Here we determine the mem-
brane topology of the C-terminal half of the glutamate
transporters by applying the phoA gene fusion tech-
nique to the homologous bacterial glutamate trans-
porter of Bacillus stearothermophilus. High sequence
conservation and very similar hydropathy profiles in
the C-terminal half warrant a similar folding as in the
glutamate transporters of the mammalian central nerv-
ous system. The C-terminal half contains four putative
transmembrane helices. The strong hydrophobic mo-
ment and substitution moment of the most C-terminal
helix X that point to opposite faces of the helix suggest
that the helix faces the lipid environment with its least
conserved, hydrophobic face and the interior of the pro-
tein with its well conserved, hydrophilic face. Residues
that were shown before to be critical for function cluster
in helix X and VII.
Glutamate is the predominant excitatory neurotransmitter
in the mammalian central nervous system. High affinity Na1-
and K1-dependent glutamate transporters in presynaptic
nerve terminals and glial cells terminate the transmission by
removing the neurotransmitter from the synaptic cleft and are
essential to keep the extracellular concentration of glutamate
below neurotoxic levels (1). Impaired glutamate uptake has
been implicated with neurodegenerative diseases (2). Gluta-
mate transporters from different mammalian sources have
been cloned and sequenced and were characterized electro-
physiologically and biochemically (15–18), but the understand-
ing of the molecular basis of transport is hampered by a lack of
structural information on the transporters.
The neuronal and glial glutamate transporters belong to a
family of homologous transporter proteins in which also gluta-
mate transporters from prokaryotic origin are found. Align-
ment of the primary sequences in the family reveals about 30%
sequence identity between the prokaryotic and eukaryotic
members. In spite of this low degree of sequence conservation,
the hydropathy profiles of the transporters are well conserved,
suggesting that their membrane topology and global structure
is the same (3). Several models have been proposed for the
membrane topology of the individual members of the family.
These models univocally predict six transmembrane helices in
the N-terminal half of the proteins, but there is no consensus
about the topology of the C-terminal half. Models with zero,
two, and four helices in this part of the protein have been
proposed (3, 15–17). This is unfortunate because in particular
the C-terminal half of the glutamate carriers is the best con-
served part of the proteins and has been postulated to consti-
tute the translocation pathway (4). Evidence supporting the
hypothesis comes frommutagenesis studies with the glutamate
transporters GLAST and GLT-1 from rat brain by which sev-
eral residues in the C-terminal half were identified that are
critical for the function of the transporters (5, 6). Furthermore,
the binding site of dihydrokainic acid, a glutamate analogue,
has been located in the C-terminal half of the human excitatory
glutamate transporter EAAT2 (7).
In this study the membrane topology of the C-terminal half
of one member of the family of glutamate transporters, GltT of
Bacillus stearothermophilus, is determined using the well es-
tablished phoA-gene fusion approach (22). A total of 19 GltT-
PhoA fusion proteins with fusion sites at approximately every
sixth residue in the primary sequence of the C-terminal half of
GltT were constructed. Clusters of fusion proteins with low and
high alkaline phosphatase activity alternate along the primary
sequence of GltT, indicating the presence of 4 transmembrane
helices in addition to the 6 predicted helices in the N-terminal
half.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions—Escherichia coli strain
JM101 expressing the GltT derivatives was grown in Luria Broth (LB)
medium containing carbenicillin at a concentration of 100 mg/ml at
37 °C. The constructs were expressed in the absence of isopropyl-1-thio-
b-D-galactopyranoside. The cells were screened for alkaline phospha-
tase activity by plating on LB agar plates containing 40 mg/ml 5-bromo-
4-chloroindolyl phosphate (XP).1
Construction of gltT-phoA Gene Fusions—Standard recombinant
DNA procedures were used essentially as described by Sambrook et al.
(8). Plasmid pGltThis codes for the GltT protein with 6 additional
histidine residues (His-tag) at the N terminus and is routinely used as
the expression vector for the purification of the protein (9). pGltThis
contains a unique HindIII restriction site in the first half of the gltT
gene and a unique XbaI site downstream of the gene. The polymerase
chain reaction technique was used to amplify fragments of the gltT gene
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from the HindIII site to the desired fusion site where a NcoI site was
introduced in the fragment. The ATG bases of the NcoI sites were in
frame with the coding sequence. The polymerase chain reaction prod-
ucts were restricted with HindIII and NcoI and cloned in vector
pSKphoA that contains the coding sequence for the mature form of
alkaline phosphatase starting with a NcoI site and flanked by unique
HindIII (upstream) and XbaI (downstream) restriction sites (11). In the
resulting vector, the phoA gene is fused to the gltT fragments. Finally,
the HindIII-XbaI fragments of these plasmids were cloned back into
pGltThis digested with the same enzymes which results in the complete
gltT-phoA gene fusions. The nucleotide sequences of the amplified gltT
fragments were confirmed on a Vistra 725 automated Sequencer.
Alkaline Phosphatase Activities and Immunoblot Analysis—Alkaline
phosphatase activities of exponentially growing cells were quantified by
measuring the rate of p-nitrophenyl phosphate hydrolysis essentially as
described by Michaelis et al. (10) with minor modifications according to
Van Geest and Lolkema (11). Immunoblot analysis of exponentially
growing cells expressing GltT-PhoA fusion proteins was performed as
described by Van Geest and Lolkema (11) using a monoclonal antibody
directed against alkaline phosphatase. Antibodies were visualized us-
ing the Western light chemiluminescence detection kit (Tropix).
Sequence Analysis—A selection of 7 representative homologous glu-
tamate transporters were included in the analysis. All other homolo-
gous glutamate transporters in the data bases share at least 90%
sequence identity with one of these sequences. The family includes
GLT1 of Rattus norvegicus (EMBL Databank accession number
X67857) (15), GLAST of R. norvegicus (X63744) (16), EAAC1 of Oryc-
tolagus cuniculus (L12411) (17), EAAT4 ofHomo sapiens (U18244) (18),
GltP of E. coli (M84805) (19), GltP of Bacillus subtilis (U15147) (20),
and GltT of B. stearothermophilus (M86508) (21). Multiple sequence
alignments were performed using the program ClustalV (12). Hydrop-
athy profiles were calculated using the normalized hydrophobicity scale
of Kyte (13). Profiles of the hydrophobic moment and substitution
moment with a-helical periodicity were calculated using the method of
Eisenberg (13) with the normalized hydrophobicity scale of Kyte and
the substitution table of Donnelly et al. (14), respectively.
RESULTS
Hydropathy Profile Analysis—Fig. 1 shows the average hy-
dropathy profile of the aligned primary sequences of the C-
terminal half of the family of neuronal, glial, and bacterial
glutamate transporters. The region between position 410 and
530 is present in all sequences and does not contain any gaps in
the alignment. The profile reveals one large hydrophobic region
with very little structure when a window size of 21 residues is
used which makes it difficult to assign transmembrane seg-
ments (Fig. 1A). The lack of structure is not a consequence of
the averaging of the different sequences in the family. Reduc-
ing the window size to 11 residues reveals a “fine structure” in
the profile that is extremely well conserved throughout the
family. The profile of the individual GltT sequence that is
indicated separately in Fig. 1B almost coincides with the aver-
age profile. The strong conservation of the hydropathy profiles
throughout the family indicates that the membrane topology of
all members is the same and that the topology of any member
can be used as a model for the others.
GltT-PhoA Fusion Proteins—The glutamate transporter
GltT of B. stearothermophilus was selected as the model to
determine the membrane topology of the C-terminal half of the
glutamate transporter family. The GltT protein can be ex-
pressed in E. coli in a functional form (9, 21), allowing the well
documented alkaline phosphatase (phoA)-gene fusion tech-
nique to determine the disposition of the polypeptide chain in
the membrane (22). Alkaline phosphatase was fused to C-
terminally truncated GltT molecules at the 19 sites indicated
by the arrows in Fig. 1. The spacing between the sites is
approximately 6 residues.
Expression of the GltT-PhoA fusion proteins in E. coli re-
sulted in two different phenotypes when the cells were plated
on LB agar containing the chromogenic substrate for alkaline
phosphatase. The cells grew either as blue or white colonies,
indicative of high and low alkaline phosphatase activity, re-
spectively. The activity was quantified by measuring the rate of
hydrolysis of p-nitrophenyl phosphate catalyzed by the cells
expressing the different fusion proteins in suspension. Cells
with a blue phenotype on XP plates showed at least a 10-fold
higher alkaline phosphatase activity than cells with a white
FIG. 1. Hydropathy profile analysis of the C-terminal half of
the aligned set of glutamate transporters. Hydropathy profiles
were calculated using a window of 21 (A) and 11 (B) residues. Position
numbers refer to the positions in the alignment. Bold and thin lines
indicate average profiles and the GltT profiles, respectively. Arrows and
bars indicate the fusion sites in the GltT-PhoA fusions and the mem-
brane spanning helices, respectively.
FIG. 2. Alkaline phosphatase activity of cells expressing GltT-
PhoA fusion proteins. The average value of three measurements is
shown. The numbers indicating the fusion sites refer to the residue
numbers in the sequence of GltT, whereas the positions in the multiple
sequence alignment (as in Fig. 1) are shown in parentheses. Hatched
and open bars indicate cells expressing hybrid proteins that appear as
blue and white colonies on indicator plates containing the chromogenic
substrate for alkaline phosphatase 5-bromo-4-chloro-5-indolyl phos-
phate, respectively.
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phenotype (Fig. 2). Expression of the GltT-PhoA fusion proteins
was demonstrated by Western blot analysis using a monoclonal
antibody against PhoA (Fig. 3). The experiments were carried
out with the same batches of cells that were used to determine
the PhoA activities of the fusion proteins. E. coli JM101 ex-
pressing wild type GltT and grown in rich medium does not
express chromosomally encoded alkaline phosphatase as is ev-
ident from the lack of signal in lanes A14 and B1. In all cases,
the full-length GltT-PhoA fusion protein is observed increasing
in size from about 70 kDa for the most N-terminal fusion at
residue 278 to 84 kDa for the C-terminal fusion. The lower
molecular weight bands represent breakdown products. There
is no clear correlation between the blue and white phenotype of
the cells (Fig. 2), and the level of expression or the stability of
the fusion proteins. This is in contrast to other phoA-gene
fusion studies where PhoA fusion proteins conferring low alka-
line phosphatase activity were rapidly degraded while fusion
proteins conferring high activity were stable (e.g. Refs. 11 and
23). Here, we conclude that the activity of the different fusion
proteins correlates with low specific activity rather than low
expression levels.
The Topology Model—The fusion sites in the GltT-PhoA fu-
sion proteins resulting in low and high PhoA activities group
into three and two clusters, respectively, that alternate along
the primary sequence of GltT (Fig. 2). Since PhoA is only active
when translocated to the periplasm, the fusion sites in the
proteins with high PhoA activities are at the periplasmic side of
the membrane, whereas the fusion sites in the proteins with
low PhoA activities are at the cytoplasmic side of the mem-
brane (22). This indicates the presence of four membrane span-
ning segments in the C-terminal half of the glutamate carriers.
Detailed studies with the lactose permease, LacY, and the
melibiose carrier, MelB, from E. coli have demonstrated that
the N-terminal half of an outgoing transmembrane helix is
sufficient to export the PhoA moiety fused to a membrane
protein while the N-terminal half of an ingoing transmembrane
helix is sufficient to prevent the export of the PhoA moiety to
the periplasm (23, 24). This suggests that the middle of a
transmembrane helix is located in between fusion sites result-
ing in high and low alkaline phosphatase activity. The alkaline
phosphatase activity profile of the fusion sites in GltT shows
remarkably sharp transitions between sites that are only 6 to
10 residues apart which localizes the middle of the transmem-
brane segments in between residues 317 and 325, 331 and 338,
356 and 362, and between 375 and 386. This together with the
FIG. 3. Western blot analysis of cells expressing GltT-PhoA
fusions. Cells expressing fusion proteins were run on a 10% SDS-
polyacrylamide gel and detected using a monoclonal antibody directed
against PhoA. A, lanes 1–13, cells expressing GltT with PhoA fused at
residues 278, 284, 290, 297, 303, 310, 317, 325, 331, 338, 344, 350, and
356, respectively; lane 14, cells expressing wild type GltT. B, lanes 2–7,
cells expressing GltT with PhoA fused at residues 362, 368, 375, 386,
394, and 422, respectively; lane 1, cells expressing wild type GltT. The
arrow indicates the fusion proteins.
FIG. 4. Model for the membrane to-
pology of the C-terminal half of the
glutamate transporter family. The se-
quence of GltT is shown, and residue
numbers refer to the GltT sequence while
the positions in the multiple sequence
alignment are shown in parentheses. The
putative membrane spanning helices VII
through X are indicated in boxes. The
fusion sites in the GltT-PhoA hybrids
with high and low alkaline phosphatase
activity are shown in black and gray,
respectively.
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assumption that a transmembrane segment requires about 20
residues to traverse the membrane results in the topology
model for the C-terminal half of GltT presented in Fig. 4.
DISCUSSION
The membrane topology of the C-terminal half of the neuro-
nal, glial, and bacterial glutamate transporter family was de-
termined with the phoA-gene fusion technique using GltT of B.
stearothermophilus as the representative model. The results
reveal the presence of four membrane spanning segments,
which, taken together with the 6 membrane helices that have
been predicted in the N-terminal half of the protein (3), results
in a total of 10 transmembrane helices in the glutamate trans-
porters. The folding model for the C-terminal half presented in
Fig. 4 is in agreement with trypsin digestion studies performed
with membrane vesicles from rat brain containing GLT-1 (25).
These studies showed that an antibody epitope near the C
terminus of the transporter as well as an epitope between
residues 372 and 386 in the sequence of GLT-1, corresponding
to residues 278 to 292 in the sequence of GltT (Fig. 4), are
located at the cytoplasmic side of the membrane.
The location of the four putative transmembrane helices is
indicated in the hydropathy profiles of Fig. 1. The first three
helices (helices VII, VIII, and IX) roughly coincide with peaks
in the hydropathy profile when a small window size is used
indicating that at least the core of these helices is hydrophobic
(Fig. 1B). However, the membrane spanning segment that is
located closest to the C terminus of the protein (helix X) is not
very hydrophobic. It contains several well conserved charged
and polar residues that have to be accommodated in the apolar
core of the membrane. To provide more insight in the structure
of this segment, the periodicity profile approach of Eisenberg
was used (13, 26). Putative transmembrane helix X exhibits
exceptionally strong hydrophobic and substitution moments
with a-helical periodicity (Fig. 5, A and B). The hydrophobic
moment is large compared to highly amphipatic helices in
known structures, e.g. the peptide melittin has a hydrophobic
moment of 0.4/residue (13) which compares to 0.49/residue for
helix X on the same hydrophobicity scale. The hydrophobic
moment is extremely well conserved throughout the family and
indicates a helical structure that is hydrophobic at one face and
hydrophilic at the opposite face. Similarly, the large substitu-
tion moment follows from clustering of conserved residues at
one face of the helix. In the crystal structure of the bacterial
reaction center, the least conserved residues of a transmem-
brane helix tend to face the lipids whereas the more conserved
residues are buried in the protein interior (26). A helical wheel
representation of putative transmembrane helix X shows that
the hydrophobic and substitution moments point to opposite
faces of the helix (Fig. 5C). The least conserved face of the helix
is hydrophobic whereas the conserved residues are at the op-
posite hydrophilic side. Consequently, the transmembrane he-
lix could have a lipid-exposed hydrophobic face and a hydro-
philic face of conserved residues that interact with hydrophilic
residues on adjacent transmembrane segments. Polar and
charged residues are not expected in the hydrophobic core of
the membrane unless they are essential for the function of the
protein. Indeed, two conserved hydrophilic residues in trans-
membrane helix X have been shown to be crucial for trans-
porter function as evidenced by the complete loss of transport
activity when Asp-470 (position 504 in the multiple sequence
alignment of Fig. 5C) in GLT1 is substituted for Asn, Gly, or
Glu and Arg-479 (position 511) in GLAST is substituted for Thr
(5, 6). The hydrophilic residues of amphipatic helix X form a
hydrophilic surface that spans the entire apolar core of the
membrane and can provide the pathway for the translocation of
glutamate and/or the co-ions through the protein.
Three other polar or charged residues that have been shown
to be important for the function of the glutamate transporters
from rat brain are located in helix VII. Asp-398 in GLT-1
(corresponding to Asp-304 in the sequence of GltT in Fig. 4) and
FIG. 5. Periodicity profile analysis of the C-terminal half of the
glutamate transporters family. Profiles of the hydrophobic moment
(A) and substitution moment (B) with a-helical periodicity using a
window of 21 residues. The moments are given per residue. Position
numbers refer to the positions in the multiple sequence alignment. Bold
and thin lines indicate average profiles and the GltT profiles, respec-
tively. Arrows and bars indicate the fusion sites in the GltT-PhoA
fusions and the membrane spanning helices, respectively. C, helical
wheel representation of the hydrophobic moment and substitution mo-
ment of putative helix X. The hydrophobic moment averaged over the
family and given per residue (right arrow; scale 0.6), and the substitu-
tion moment per residue (left arrow; scale 0.1) were calculated for the
stretches shown in bold in the alignment below. The sequence of GltT is
shown on the wheel. The numbers in the top line of the multiple se-
quence alignment refer to the position numbers in the alignment, and
the symbols ; and * indicate similar and identical residues, respec-
tively. The residue numbering of the individual sequences is shown on
each side of the sequences. The triangles indicate the fusion sites in the
GltT-PhoA fusion proteins.
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Tyr-405 in GLAST (Tyr-309 in GltT) are essential for transport
of glutamate whereas mutation of the nonconserved residue
Glu-404 in GLT-1 (Gln-310 in GltT) changes the substrate
specificity of the transporter (5, 6). Helix VII is also part of the
stretch that contains the binding site of the glutamate ana-
logue dihydrokainic acid in the human excitatory glutamate
transporter EAAT2 (7). Therefore, helices VII and X may pro-
vide an important part of the binding site and translocation
path in the glutamate carriers.
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